Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
standard and novel models of cardiovascular inflammation, as well as rare human biospecimens and have most recently established a dedicated therapeutic mRNA program. All of these projects have a strong
-
-centric innovations, we aim to build a resilient agricultural and environmental future. Central to this effort is our AgriTwins program (a part of the CSIRO Next Generation Graduates Programs ), a
-
to both access critical unique cohorts and human tissue samples and also to perform investigator-initiated clinical studies and trials. The current major focus of the Immunology Programs is to discover
-
Poche Fellow in Melanoma and Surgical Oncology Applications are invited from qualified General or Plastic Surgeons for the Poche Fellowship in Melanoma and Surgical Oncology. This program is based
-
Engineering The College of Science and Engineering is a comprehensive provider of world class research and undergraduate and postgraduate programs in a range of science, technology and engineering disciplines
-
, Masters and PhD students, as well as post-doctoral research fellows. What you would be doing: You will be expected to bring or develop a research programme in bacterial/fungal infection biology. You will
-
, research, service and engagement. In this position you will engage in undergraduate and postgraduate teaching and curriculum development. You will have a developed research program and conduct high- quality
-
-disciplinary research is encouraged. SOLES has a program of undergraduate teaching in agriculture from first year to Honours/Masters level and the successful applicant will be expected to contribute across
-
curriculum design, coordinate courses, assess students, provide academic counselling, and adhere to university teaching rules. Contribute to the development and improvement of programs and course materials in
-
Doctoral Scientist position. This position will report to Professor Jose Polo, Lead of the Cancer Epigenetics Program at the South Australian Immunogenomics Cancer Institute (SAiGENCI) and the Inaugural